Elevated serum and BAL fluid SPP1 levels can be a potential biomarker for ILDs, and the global knockout of SPP1 can protect animals from developing pulmonary fibrosis in various experimental models of pulmonary fibrosis. Here, SPP1 is linked to pulmonary fibrosis.